Hyperosmolar hyperglycemic state risk factors

Jump to navigation Jump to search

Hyperosmolar hyperglycemic state Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperosmolar hyperglycemic state from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperosmolar hyperglycemic state risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperosmolar hyperglycemic state risk factors

CDC on Hyperosmolar hyperglycemic state risk factors

Hyperosmolar hyperglycemic state risk factors in the news

Blogs on Hyperosmolar hyperglycemic state risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Hyperosmolar hyperglycemic state risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

  • There are no established risk factors for [disease name].

OR

  • The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
  • Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common Risk Factors

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:
    • [risk factor 1]
    • [risk factor 2]
    • [risk factor 3]

References

  1. Katz JR, Edwards R, Khan M, Conway GS (1996). "Acromegaly presenting with diabetic ketoacidosis". Postgrad Med J. 72 (853): 682–3. PMC 2398638. PMID 8944212.
  2. Burzynski J (2005). "DKA and thrombosis". CMAJ. 173 (2): 132, author reply 132–3. doi:10.1503/cmaj.1050103. PMC 1174837. PMID 16027420.
  3. Jovanovic A, Stolic RV, Rasic DV, Markovic-Jovanovic SR, Peric VM (2014). "Stroke and diabetic ketoacidosis--some diagnostic and therapeutic considerations". Vasc Health Risk Manag. 10: 201–4. doi:10.2147/VHRM.S59593. PMC 3986295. PMID 24748799.
  4. Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, Lombardi G, Colao A (2010). "Pathophysiology of diabetes mellitus in Cushing's syndrome". Neuroendocrinology. 92 Suppl 1: 77–81. doi:10.1159/000314319. PMID 20829623.
  5. Pasternak DP (1974). "Hemochromatosis presenting as diabetic ketoacidosis with extreme hyperglycemia". West. J. Med. 120 (3): 244–6. PMC 1129403. PMID 4205898.
  6. Kamalakannan D, Baskar V, Barton DM, Abdu TA (2003). "Diabetic ketoacidosis in pregnancy". Postgrad Med J. 79 (934): 454–7. PMC 1742779. PMID 12954957.

Template:WH Template:WS